ACCOMPLISH study reviewed by the National Prescribing Centre
ACCOMPLISH trial analyzed by the NPC team, independent and unbiased information relevant to medical practice.
Aliskiren (Rasilez) for essential hypertension: not recommended by the NHS Scotland
The Scottish Medicines Consortium issued on 5th December 2008 an advice on aliskiren (Rasilez, Tekturna in the US): Aliskiren (Rasilez) is not recommended for use within NHS Scotland for the treatment of essential hypertension. Aliskiren has shown comparable efficacy to other antihypertensive agents in terms of blood pressure reduction, though its effects on mortality and […]
Ramipril (Tritrace): indications, contraindications and posology updated in a review by the CHMP
The CHMP has issued a question and answer document dated 18 December 2008, about the review of Titrace (ramipril) and associated names: Questions and answers on the referral for Tritace tablet and hard capsules containing ramipril 1.25 mg, 2.5 mg, 5 mg and 10 mg The European Medicines Agency (EMEA) has completed a review of […]